메뉴 건너뛰기




Volumn 139, Issue 2, 2013, Pages 201-209

KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines

Author keywords

BRAF; Cetuximab; Colorectal adenocarcinoma; EGFR; KRAS; Panitumumab; PIK3CA

Indexed keywords

B RAF KINASE; BIOLOGICAL MARKER; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; K RAS PROTEIN; PANITUMUMAB; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; ANTINEOPLASTIC AGENT; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; MONOCLONAL ANTIBODY; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; RAS PROTEIN;

EID: 84874997620     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1319-7     Document Type: Article
Times cited : (30)

References (36)
  • 4
    • 3042785708 scopus 로고    scopus 로고
    • Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: Variation in staining intensity due to choice of fixative and storage time of tissue sections
    • 15208356 10.1369/jhc.3A6195.2004 1:CAS:528:DC%2BD2cXls1alurk%3D
    • Atkins D, Reiffen KA, Tegtmeier CL, Winther H, Bonato MS, Storkel S (2004) Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 52(7):893-901
    • (2004) J Histochem Cytochem , vol.52 , Issue.7 , pp. 893-901
    • Atkins, D.1    Reiffen, K.A.2    Tegtmeier, C.L.3    Winther, H.4    Bonato, M.S.5    Storkel, S.6
  • 5
    • 76049098292 scopus 로고    scopus 로고
    • Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases
    • 20103678 10.1158/1078-0432.CCR-09-2446 1:CAS:528:DC%2BC3cXhs1aqsr4%3D
    • Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE (2010) Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 16(3):790-799
    • (2010) Clin Cancer Res , vol.16 , Issue.3 , pp. 790-799
    • Baldus, S.E.1    Schaefer, K.L.2    Engers, R.3    Hartleb, D.4    Stoecklein, N.H.5    Gabbert, H.E.6
  • 6
    • 0023068346 scopus 로고
    • Ras genes
    • 3304147 10.1146/annurev.bi.56.070187.004023 1:CAS:528:DyaL2sXkslWlurY%3D
    • Barbacid M (1987) Ras genes. Annu Rev Biochem 56:779-827
    • (1987) Annu Rev Biochem , vol.56 , pp. 779-827
    • Barbacid, M.1
  • 7
    • 77949435827 scopus 로고    scopus 로고
    • Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer
    • 20100961 10.1200/JCO.2009.24.6116 1:CAS:528:DC%2BC3cXktF2ltbk%3D
    • Bardelli A, Siena S (2010) Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol 28(7):1254-1261
    • (2010) J Clin Oncol , vol.28 , Issue.7 , pp. 1254-1261
    • Bardelli, A.1    Siena, S.2
  • 8
    • 34047248571 scopus 로고    scopus 로고
    • Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
    • 17363584 10.1158/0008-5472.CAN-06-4158 1:CAS:528:DC%2BD2sXivV2ns7w%3D
    • Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F, Zanon C, Moroni M, Veronese S, Siena S, Bardelli A (2007) Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. Cancer Res 67(6):2643-2648
    • (2007) Cancer Res , vol.67 , Issue.6 , pp. 2643-2648
    • Benvenuti, S.1    Sartore-Bianchi, A.2    Di Nicolantonio, F.3    Zanon, C.4    Moroni, M.5    Veronese, S.6    Siena, S.7    Bardelli, A.8
  • 9
    • 33748533501 scopus 로고    scopus 로고
    • Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray
    • 16865406 10.1007/s00428-006-0247-9 1:CAS:528:DC%2BD28XptF2kt7k%3D
    • Bibeau F, Boissiere-Michot F, Sabourin JC, Gourgou-Bourgade S, Radal M, Penault-Llorca F, Rochaix P, Arnould L, Bralet MP, Azria D, Ychou M (2006) Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray. Virchows Arch 449(3):281-287
    • (2006) Virchows Arch , vol.449 , Issue.3 , pp. 281-287
    • Bibeau, F.1    Boissiere-Michot, F.2    Sabourin, J.C.3    Gourgou-Bourgade, S.4    Radal, M.5    Penault-Llorca, F.6    Rochaix, P.7    Arnould, L.8    Bralet, M.P.9    Azria, D.10    Ychou, M.11
  • 14
    • 0027209054 scopus 로고
    • Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis
    • 8489386 10.1001/archsurg.1993.01420170056008 1:STN:280: DyaK3s3ls1Onug%3D%3D discussion 531-522
    • Finkelstein SD, Sayegh R, Bakker A, Swalsky P (1993) Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 128(5):526-531 discussion 531-522
    • (1993) Arch Surg , vol.128 , Issue.5 , pp. 526-531
    • Finkelstein, S.D.1    Sayegh, R.2    Bakker, A.3    Swalsky, P.4
  • 15
    • 0034548712 scopus 로고    scopus 로고
    • K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression
    • 11118062 1:CAS:528:DC%2BD3cXosl2it7o%3D
    • Guerrero S, Casanova I, Farre L, Mazo A, Capella G, Mangues R (2000) K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Cancer Res 60(23):6750-6756
    • (2000) Cancer Res , vol.60 , Issue.23 , pp. 6750-6756
    • Guerrero, S.1    Casanova, I.2    Farre, L.3    Mazo, A.4    Capella, G.5    Mangues, R.6
  • 17
    • 24044460118 scopus 로고    scopus 로고
    • Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: Biological and clinical implications
    • 15980160 10.1093/annonc/mdi282 1:STN:280:DC%2BD2MrjtlGhtg%3D%3D
    • Italiano A, Saint-Paul MC, Caroli-Bosc FX, Francois E, Bourgeon A, Benchimol D, Gugenheim J, Michiels JF (2005) Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications. Ann Oncol 16(9):1503-1507
    • (2005) Ann Oncol , vol.16 , Issue.9 , pp. 1503-1507
    • Italiano, A.1    Saint-Paul, M.C.2    Caroli-Bosc, F.X.3    Francois, E.4    Bourgeon, A.5    Benchimol, D.6    Gugenheim, J.7    Michiels, J.F.8
  • 23
    • 52749099497 scopus 로고    scopus 로고
    • Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: A systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
    • 18804418 10.1016/S1470-2045(08)70206-7 1:CAS:528:DC%2BD1cXhtFOmurvJ
    • Linardou H, Dahabreh IJ, Kanaloupiti D, Siannis F, Bafaloukos D, Kosmidis P, Papadimitriou CA, Murray S (2008) Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol 9(10):962-972
    • (2008) Lancet Oncol , vol.9 , Issue.10 , pp. 962-972
    • Linardou, H.1    Dahabreh, I.J.2    Kanaloupiti, D.3    Siannis, F.4    Bafaloukos, D.5    Kosmidis, P.6    Papadimitriou, C.A.7    Murray, S.8
  • 24
    • 37349063195 scopus 로고    scopus 로고
    • Immune activation by epidermal growth factor receptor specific monoclonal antibody therapy for head and neck cancer
    • 10.1001/archotol.133.12.1277
    • Lopez-Albaitero A, Ferris RL (2007) Immune activation by epidermal growth factor receptor specific monoclonal antibody therapy for head and neck cancer. Arch Otollanyngol Head Neck Surg 133:1277-1281
    • (2007) Arch Otollanyngol Head Neck Surg , vol.133 , pp. 1277-1281
    • Lopez-Albaitero, A.1    Ferris, R.L.2
  • 26
    • 70450195266 scopus 로고    scopus 로고
    • Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
    • 19636327 10.1038/nrclinonc.2009.111 1:CAS:528:DC%2BD1MXhtVKjsrjO
    • Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F (2009) Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol 6(9):519-527
    • (2009) Nat Rev Clin Oncol , vol.6 , Issue.9 , pp. 519-527
    • Normanno, N.1    Tejpar, S.2    Morgillo, F.3    De Luca, A.4    Van Cutsem, E.5    Ciardiello, F.6
  • 29
    • 84872604206 scopus 로고    scopus 로고
    • Mutant (MT) KRAS codon 12 and 13 alleles in patients (pts) with metastatic colorectal cancer (mCRC): Assessment as prognostic and predictive biomarkers of response to panitumumab (pmab)
    • abstr 383
    • Peeters M, Douillard JY, Van Cutsem E, Siena S, Zhang K, Williams RT et al. (2012) Mutant (MT) KRAS codon 12 and 13 alleles in patients (pts) with metastatic colorectal cancer (mCRC): assessment as prognostic and predictive biomarkers of response to panitumumab (pmab). J Clin Oncol 30(suppl); abstr 383
    • (2012) J Clin Oncol , vol.30 , Issue.SUPPL.
    • Peeters, M.1    Douillard, J.Y.2    Van Cutsem, E.3    Siena, S.4    Zhang, K.5    Williams, R.T.6
  • 31
    • 70349939382 scopus 로고    scopus 로고
    • Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer
    • 19738166 10.1093/jnci/djp280 1:CAS:528:DC%2BD1MXht1Ojt73I
    • Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A (2009) Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst 101(19):1308-1324
    • (2009) J Natl Cancer Inst , vol.101 , Issue.19 , pp. 1308-1324
    • Siena, S.1    Sartore-Bianchi, A.2    Di Nicolantonio, F.3    Balfour, J.4    Bardelli, A.5
  • 34
    • 84867117207 scopus 로고    scopus 로고
    • Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab
    • 10.1200/JCO.2012.42.2592
    • Tejpar S, Celik I, Schlichting M, Sartorius U, Bokemeyer C, Van Cutsem E (2012) Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab. J Clin Oncol. doi: 10.1200/JCO.2012.42.2592
    • (2012) J Clin Oncol
    • Tejpar, S.1    Celik, I.2    Schlichting, M.3    Sartorius, U.4    Bokemeyer, C.5    Van Cutsem, E.6
  • 36
    • 0035117355 scopus 로고    scopus 로고
    • Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
    • 11255078 10.1016/S1040-8428(00)00134-7 1:STN:280:DC%2BD3MrgsVCrsg%3D%3D
    • Yang XD, Jia XC, Corvalan JR, Wang P, Davis CG (2001) Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy. Crit Rev Oncol Hematol 38(1):17-23
    • (2001) Crit Rev Oncol Hematol , vol.38 , Issue.1 , pp. 17-23
    • Yang, X.D.1    Jia, X.C.2    Corvalan, J.R.3    Wang, P.4    Davis, C.G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.